Senseonics Holdings, Inc.
SENS Healthcare Medical Devices
Senseonics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.3 million, up 56.9% from fiscal 2024. In the quarter to June 2026, revenue grew 117.8%, EPS fell 57.5%, free cash flow fell 223.2% and total debt rose 58.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow SENS
Senseonics Holdings, Inc. (SENS) P/E ratio
Senseonics Holdings, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 32.8× (March 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 3.4× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 40 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SI Shoulder Innovations, Inc. compare | n/m |
| SENS Senseonics Holdings, Inc. | n/m |
| OFIX ORTHOFIX MEDICAL INC. compare | n/m |
| SGHT Sight Sciences, Inc. compare | n/m |
| CERS Cerus Corporation compare | n/m |
| MASS 908 Devices Inc. compare | n/m |
| NPCE NeuroPace, Inc. compare | n/m |
| BWAY Brainsway Ltd. Sponsored ADR compare | 24.8× |
| VMD Viemed Healthcare, Inc. compare | 24.9× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)